PineBridge Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $92.9M | Buy |
101,032
+3,559
| +4% | +$3.61M | 0.78% | 25 |
|
|
2025
Q4 | $105M | Sell |
97,473
-32,210
| -25% | -$30.8M | 0.77% | 26 |
|
|
2025
Q3 | $98.9M | Buy |
129,683
+40,191
| +45% | +$29.9M | 0.73% | 20 |
|
|
2025
Q2 | $69.8M | Buy |
89,492
+2,386
| +3% | +$1.85M | 0.55% | 27 |
|
|
2025
Q1 | $71.9M | Buy |
87,106
+1,904
| +2% | +$1.58M | 0.57% | 36 |
|
|
2024
Q4 | $65.8M | Sell |
85,202
-57,194
| -40% | -$47.4M | 0.5% | 35 |
|
|
2024
Q3 | $126M | Buy |
142,396
+25,449
| +22% | +$22.9M | 0.95% | 14 |
|
|
2024
Q2 | $106M | Sell |
116,947
-56,607
| -33% | -$45.3M | 0.85% | 15 |
|
|
2024
Q1 | $135M | Buy |
173,554
+42,127
| +32% | +$30M | 1.08% | 14 |
|
|
2023
Q4 | $76.6M | Buy |
131,427
+21,157
| +19% | +$12.3M | 0.71% | 23 |
|
|
2023
Q3 | $59.2M | Buy |
110,270
+43,227
| +64% | +$22.3M | 0.66% | 24 |
|
|
2023
Q2 | $31.4M | Buy |
67,043
+4,750
| +8% | +$1.99M | 0.34% | 77 |
|
|
2023
Q1 | $21.4M | Buy |
62,293
+2,508
| +4% | +$846K | 0.24% | 112 |
|
|
2022
Q4 | $21.9M | Sell |
59,785
-12,666
| -17% | -$4.49M | 0.26% | 106 |
|
|
2022
Q3 | $23.4M | Sell |
72,451
-11,972
| -14% | -$3.79M | 0.3% | 89 |
|
|
2022
Q2 | $27.4M | Sell |
84,423
-3,717
| -4% | -$1.12M | 0.34% | 67 |
|
|
2022
Q1 | $25.2M | Buy |
88,140
+5,644
| +7% | +$1.45M | 0.27% | 94 |
|
|
2021
Q4 | $22.8M | Buy |
82,496
+7,380
| +10% | +$1.87M | 0.23% | 107 |
|
|
2021
Q3 | $17.4M | Sell |
75,116
-733
| -1% | -$181K | 0.21% | 124 |
|
|
2021
Q2 | $17.4M | Buy |
75,849
+10,156
| +15% | +$2.04M | 0.2% | 129 |
|
|
2021
Q1 | $12.3M | Sell |
65,693
-15,441
| -19% | -$3.02M | 0.16% | 164 |
|
|
2020
Q4 | $13.7M | Sell |
81,134
-17,238
| -18% | -$2.57M | 0.21% | 117 |
|
|
2020
Q3 | $14.6M | Buy |
98,372
+35,978
| +58% | +$5.57M | 0.25% | 100 |
|
|
2020
Q2 | $10.2M | Buy |
62,394
+60,894
| +4,060% | +$9.35M | 0.2% | 132 |
|
|
2020
Q1 | $208K | Sell |
1,500
-149,184
| -99% | -$20.5M | ﹤0.01% | 485 |
|
|
2019
Q4 | $19.8M | Sell |
150,684
-13,213
| -8% | -$1.53M | 0.3% | 89 |
|
|
2019
Q3 | $18.3M | Buy |
163,897
+60,817
| +59% | +$6.77M | 0.3% | 90 |
|
|
2019
Q2 | $11.4M | Buy |
+103,080
| New | +$12.1M | 0.19% | 146 |
|
|
2019
Q1 | – | Sell |
-470
| Closed | -$54K | – | 1122 |
|
|
2018
Q4 | $54K | Buy |
+470
| New | +$52.5K | ﹤0.01% | 954 |
|
|
2018
Q3 | – | Sell |
-13,643
| Closed | -$1.16M | – | 1136 |
|
|
2018
Q2 | $1.16M | Sell |
13,643
-278,078
| -95% | -$22.8M | 0.03% | 565 |
|
|
2018
Q1 | $22.6M | Buy |
291,721
+85,192
| +41% | +$6.86M | 0.53% | 37 |
|
|
2017
Q4 | $17.4M | Buy |
206,529
+74,985
| +57% | +$6.38M | 0.45% | 55 |
|
|
2017
Q3 | $11.3M | Buy |
131,544
+41,603
| +46% | +$3.41M | 0.27% | 98 |
|
|
2017
Q2 | $7.4M | Buy |
+89,941
| New | +$7.34M | 0.19% | 128 |
|
|
2016
Q4 | – | Sell |
-77
| Closed | -$6K | – | 1201 |
|
|
2016
Q3 | $6K | Sell |
77
-1,284
| -94% | -$103K | ﹤0.01% | 1098 |
|
|
2016
Q2 | $108K | Buy |
1,361
+920
| +209% | +$69.3K | 0.01% | 734 |
|
|
2016
Q1 | $32K | Buy |
441
+220
| +100% | +$16.6K | ﹤0.01% | 1008 |
|
|
2015
Q4 | $19K | Buy |
+221
| New | +$18.3K | ﹤0.01% | 1060 |
|
|
2015
Q1 | – | Sell |
-5,134
| Closed | -$354K | – | 1124 |
|
|
2014
Q4 | $354K | Hold |
5,134
| – | – | 0.01% | 494 |
|
|
2014
Q3 | $333K | Sell |
5,134
-39,146
| -88% | -$2.48M | 0.01% | 475 |
|
|
2014
Q2 | $2.75M | Sell |
44,280
-8,078
| -15% | -$482K | 0.11% | 192 |
|
|
2014
Q1 | $3.08M | Sell |
52,358
-369,120
| -88% | -$20.6M | 0.1% | 181 |
|
|
2013
Q4 | $21.5M | Sell |
421,478
-16,783
| -4% | -$840K | 0.64% | 35 |
|
|
2013
Q3 | $22.1M | Buy |
438,261
+2,488
| +0.6% | +$130K | 0.68% | 34 |
|
|
2013
Q2 | $21.4M | Buy |
+435,773
| New | +$23.7M | 0.68% | 34 |
|
Other funds holding LLY
VCM
VPM
PineBridge Investments's LLY Position: Q1 2026 in Review
PineBridge Investments increased its Eli Lilly (LLY) stake by 3.7% in Q1 2026, buying an estimated $3.61M and bringing the position to 101,032 shares worth $92.9M. The position accounts for 0.78% of the portfolio, ranked #25.
PineBridge Investments first reported a position in LLY in Q2 2013 and has held it in 45 quarters since. The position peaked at $135M in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- PineBridge Investments held 101,032 shares of Eli Lilly worth $92.9M as of Q1 2026.
- PineBridge Investments bought 3,559 Eli Lilly shares in Q1 2026, an estimated $3.61M.
- Eli Lilly made up 0.78% of PineBridge Investments's portfolio in Q1 2026, its #25 holding.
- PineBridge Investments first reported a position in Eli Lilly in Q2 2013 and has held it in 45 quarters since.
- PineBridge Investments's Eli Lilly position peaked at $135M in Q1 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on PineBridge Investments's 13F filing for Q1 2026, filed 14 May 2026.